These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666 [TBL] [Abstract][Full Text] [Related]
23. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. Briguori C; Colombo A; Airoldi F; Focaccio A; Iakovou I; Chieffo A; Michev I; Montorfano M; Bonizzoni E; Ricciardelli B; Condorelli G Am Heart J; 2005 Oct; 150(4):807-13. PubMed ID: 16209986 [TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. Thiele H; Neumann-Schniedewind P; Jacobs S; Boudriot E; Walther T; Mohr FW; Schuler G; Falk V J Am Coll Cardiol; 2009 Jun; 53(25):2324-31. PubMed ID: 19539141 [TBL] [Abstract][Full Text] [Related]
25. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445 [TBL] [Abstract][Full Text] [Related]
26. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592 [TBL] [Abstract][Full Text] [Related]
27. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. Valgimigli M; Malagutti P; Aoki J; Garcia-Garcia HM; Rodriguez Granillo GA; van Mieghem CA; Ligthart JM; Ong AT; Sianos G; Regar E; Van Domburg RT; De Feyter P; de Jaegere P; Serruys PW J Am Coll Cardiol; 2006 Feb; 47(3):507-14. PubMed ID: 16458128 [TBL] [Abstract][Full Text] [Related]
28. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639 [TBL] [Abstract][Full Text] [Related]
29. The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary intervention. Aoki J; Ong A; Rodriguez-Granillo G; VanMieghem C; Daemen J; Sonnenschein K; McFadden E; Sianos G; van der Giessen W; de Feyter P; van Domburg R; Serruys P J Invasive Cardiol; 2005 Jul; 17(7):344-8. PubMed ID: 16003016 [TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Price MJ; Sawhney N; Kao JA; Madrid A; Schatz RA; Teirstein PS Catheter Cardiovasc Interv; 2005 Jun; 65(2):208-11. PubMed ID: 15880798 [TBL] [Abstract][Full Text] [Related]
31. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Daemen J; Ong AT; Stefanini GG; Tsuchida K; Spindler H; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW Am J Cardiol; 2006 Oct; 98(7):895-901. PubMed ID: 16996869 [TBL] [Abstract][Full Text] [Related]
32. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Tsuchida K; Colombo A; Lefèvre T; Oldroyd KG; Guetta V; Guagliumi G; von Scheidt W; Ruzyllo W; Hamm CW; Bressers M; Stoll HP; Wittebols K; Donohoe DJ; Serruys PW Eur Heart J; 2007 Feb; 28(4):433-42. PubMed ID: 17267457 [TBL] [Abstract][Full Text] [Related]
33. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Ge L; Iakovou I; Cosgrave J; Chieffo A; Montorfano M; Michev I; Airoldi F; Carlino M; Melzi G; Sangiorgi GM; Corvaja N; Colombo A Eur Heart J; 2005 Jun; 26(11):1056-62. PubMed ID: 15817605 [TBL] [Abstract][Full Text] [Related]
34. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Lemos PA; Lee CH; Degertekin M; Saia F; Tanabe K; Arampatzis CA; Hoye A; van Duuren M; Sianos G; Smits PC; de Feyter P; van der Giessen WJ; van Domburg RT; Serruys PW J Am Coll Cardiol; 2003 Jun; 41(11):2093-9. PubMed ID: 12798587 [TBL] [Abstract][Full Text] [Related]
35. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297 [TBL] [Abstract][Full Text] [Related]
36. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW; J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442 [TBL] [Abstract][Full Text] [Related]
37. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries. Tanimoto S; Daemen J; Tsuchida K; García-García HM; de Jaegere P; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2007 Jan; 69(1):94-103. PubMed ID: 17139687 [TBL] [Abstract][Full Text] [Related]
38. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP; Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry. Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY; Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617 [TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry. Saia F; Piovaccari G; Manari A; Santarelli A; Benassi A; Aurier E; Sangiorgio P; Tarantino F; Geraci G; Vecchi G; Guastaroba P; Grilli R; Marzocchi A J Am Coll Cardiol; 2006 Oct; 48(7):1312-8. PubMed ID: 17010788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]